Drug developer Veru falls on bigger Q2 loss

Veru

11/05/2023 20:07

** Drug developer Veru Inc's  VERU.O  shares down 18.1% at
$1.22
    ** Company reports Q2 net loss of $38.8 mln, or $0.48 per
share, compared with a loss of $14.2 mln, or $0.18 per share, a
year earlier 
    ** Revenue falls to $6.6 mln from $13.0 mln
    ** Company's shares down 76.7% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))